142,00 € excl.VAT – 531,00 € excl.VAT
This antibody reacts with the CD29-antigen, an integrin β1. CD29 complexes with one of nine integrin α subunits to form the very late antigen (VLA) subfamily of adhesion molecules. CD29 is expressed broadly on lymphocytes, monocytes and granulocytes.
| Conjugated | |
|---|---|
| Size | |
| Regulatory Status | |
| Clone | |
| Gene ID | |
| Format | |
| Species Reactivity | |
| Isotype | |
| Tested Applications | |
| Clonality | |
| UniProt | |
| Mw | |
| Population | B- Cell, Dendrititic Cell, Endothelial Cell, Epithelial Cell, Granulocyte, Macrophage/Monocyte, NK Cell, Platelet, Stem Cell/Precursor, T-Cell |
| Volumen/test | |
| Almacenamiento | Store in the dark at 2-8°C. |
| Otros nombres | Platelet GPIIa, VLA-beta chain, beta-1 integrin chain, Fibronectin receptor subunit beta, VLA-4 subunit beta. |
| Buffer | The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3). |
| Immunogen | Human integrin beta 1. |
| Concentración | 0,05 mg/ml, 1 mg/ml |
CD29, clone VJ1/14, is a mAb intended for identification/enumerate human peripheral blood leukocytes suppressor/cytotoxic by FCM. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/10^6 cells.
Technical Data Sheet (TDS) – (English). Safety Sheet (MSDS) – (English)
| Product description | Reference | Title | Authors | Journal | Year | |
|---|---|---|---|---|---|---|
| Product description | Reference | Title | Authors | Journal | Year |